There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The dynamics of CD4(+) effector T cells (Teff cells) and CD4(+)Foxp3(+) regulatory
T cells (Treg cells) during diabetes progression in nonobese diabetic mice was investigated
to determine whether an imbalance of Treg cells and Teff cells contributes to the
development of type 1 diabetes. Our results demonstrated a progressive decrease in
the Treg cell:Teff cell ratio in inflamed islets but not in pancreatic lymph nodes.
Intra-islet Treg cells expressed reduced amounts of CD25 and Bcl-2, suggesting that
their decline was due to increased apoptosis. Additionally, administration of low-dose
interleukin-2 (IL-2) promoted Treg cell survival and protected mice from developing
diabetes. Together, these results suggest intra-islet Treg cell dysfunction secondary
to defective IL-2 production is a root cause of the progressive breakdown of self-tolerance
and the development of diabetes in nonobese diabetic mice.